Skip to main content
. 2020 Sep 17;26(1):e99–e110. doi: 10.1634/theoncologist.2020-0022

Table 4.

Comparison of the prognostic performance of the AJCC 8th edition ypTNM staging system and the modified ypTNM staging system

Variable ypTNM staging (AJCC 8th) Modified ypTNM staging p value
Development cohort (internal validation)
Harrell's C‐index a 0.589 (0.572–0.605) 0.620 (0.602–0.638) <.001
AIC b 14,867.50 14,793.55 <.001
Likelihood ratio chi‐square c 140.71 218.66 <.001
Mean difference in BIC (95% CI) d 64.94 (25.55–96.46)
NRI (95% CI) 35.54% (14.04%–43.12%) <.001
IDI (95% CI) 0.032 (0.012–0.053) .002
Validation cohort (external validation)
Harrell's C‐index a 0.631 (0.591–0.671) 0.668 (0.625–0.712) .014
AIC b 1,461.06 1,443.6 <.001
Likelihood ratio chi‐square c 28.75 45.15 <.001
Mean difference in BIC (95% CI) d 17.50 (1.98–32.88)
NRI (95% CI) e 44.26% (10.00%–66.18%) <.001
IDI (95% CI) e 0.048 (0.000–0.086) .048

Abbreviations: AIC, Akaike information criterion; AJCC 8th, American Joint Committee on Cancer 8th edition; BIC, Bayesian information criteria; CI, confidence interval; IDI, integrated discrimination improvement index; NRI, net reclassification index.

a

A higher Harrell's C‐index indicates higher discriminative ability.

b

Smaller AIC values indicate better optimistic prognostic stratification.

c

A higher likelihood ratio chi‐square score indicates better homogeneity.

d

The BIC was used to assess the overall prognostic performance of different prognostic systems via bootstrap‐resampling analysis.

e

NRI and IDI quantify the improvement by the new staging system in predicting the patient's 5‐year survival.